When we found that Bifidobacterium could inhibit gliomas by modulating microbes, metabolites, and MEK–ERK cascades through multi-omics analyses, we wanted to further analyze the effects of Bifidobacterium on immune and inflammatory responses. The gene discussed is MAPK1; the disease is central nervous system cancer.